[Form 4] Esquire Financial Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. Vice Chairman, President & CEO and director reported a disposition of 5,785 shares of common stock on 12/16/2025 at a price of $106.82 per share, coded as transaction type F. Following this transaction, the reporting person beneficially owns 270,452 shares of common stock.

These holdings include multiple grants of restricted stock that vest in three equal annual installments beginning on various dates from December 19, 2023 through January 30, 2028. The filer also holds stock options covering 29,250 shares of common stock with a $12.5 exercise price, which became exercisable on 09/01/2017 and expire on 09/01/2026 and are described as fully vested.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Sagliocca Andrew C

Role Vice Chairman, President & CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	5,785	$106.82	$618K
holding	Stock Options	--	--	--

Holdings After Transaction: Common Stock — 270,452 shares (Direct); Stock Options — 29,250 shares (Direct)

Footnotes (1)

1. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028. Stock options are fully vested.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sagliocca Andrew C

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		F		5,785	D	$106.82	270,452(1)(2)(3)(4)(5)(6)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$12.5							09/01/2017	09/01/2026	Common Stock	29,250(7)		29,250(7)	D

Explanation of Responses:

1. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.

7. Stock options are fully vested.

	/s/ Eric S. Bader, pursuant to power of attorney	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.